Biweekly intelligence on pharma & healthcare in Latin America. Regulatory moves, deals, and market signals — in 5 minutes, every other week.

Free. No spam. Unsubscribe anytime.

---

What you get

• Regulatory radar: COFEPRIS, ANVISA, ANMAT and FDA moves that affect Latin American markets
• Deal flow: M&A, licensing, and market-entry signals across pharma and healthcare
• Market signals: the trends behind the headlines, curated from hundreds of sources

Built for decision-makers at pharma companies, CROs, health agencies, and investors covering the region.